Genetic basis - caused by an in-frame 6-base pair deletion in the PITRM1 gene, specifically c.191_196del, p.(Val64_Leu65del). PITRM1 encodes for pitrilysin metallopeptidase 1, a mitochondrial protease essential for degrading mitochondrial targeting sequences and amyloid-beta. The deletion results in the loss of two amino acids, affecting protein folding and mitochondrial function. Mutation leads to mitochondrial respiratory chain deficiency in neurons, causing energy failure critical for neuronal survival.
Pathophysiology - Mitochondrial dysfunction impairs oxidative phosphorylation, leading to neuronal energy deficits. Extensive intraneuronal mitochondrial crowding and accumulation of amyloid-beta (Aβ), typically seen in neurodegenerative disorders. Progressive acute neuronal degeneration and necrosis predominantly in grey matter of the brain. Results in neurological signs like seizures and rapid brain damage.
Complications - Rapidly progressive, lethal epilepsy. Severe neurodegeneration and brain damage. Status epilepticus is often refractory to treatment. Early onset and swift progression result in poor prognosis.
Clinical Presentation - Affected Parson Russell Terrier puppies develop normally until 6–12 weeks of age. Onset of epileptic seizures, progressing rapidly to status epilepticus (continuous seizures). Neurological deterioration can lead to death. Both sexes are affected equally.
Inheritance - Autosomal recessive inheritance. Affected dogs are homozygous for the PITRM1 deletion mutation. Carriers have one mutated copy and no clinical signs but can transmit the mutation.
Why This Matters to Breeders and Vets - This disorder represents a severe, lethal early-onset epilepsy syndrome linked directly to mitochondrial dysfunction and neurodegeneration. It is one of the few identified mitochondrial-related epilepsy cases in dogs, offering a natural model for human epilepsy research. Understanding the genetic cause supports genetic counseling, testing, and breeding management.